Healthcare


 Chemist Warehouse's ASX Debut A New Era in Retail Pharmacy

Chemist Warehouse's ASX Debut A New Era in Retail Pharmacy

February 13, 2025 03:31 PM AEDT| By Team Kalkine Media

Chemist Warehouse's ASX Debut A New Era in Retail Pharmacy

 Pro Medicus Highlights 'Unprecedented Success' in US Expansion, but Market Remains Skeptical

Pro Medicus Highlights 'Unprecedented Success' in US Expansion, but Market Remains Skeptical

February 13, 2025 03:30 PM AEDT| By Team Kalkine Media

Highlights:,Pro Medicus reported significant revenue growth and major contract expansions.,Despite strong financial results, share price fluctuations occurred after the announcement.,Market response may reflect valuation concerns and profit-taking ac...

 Pro Medicus Shares Gain Limelight Following Half-year Results Update

Pro Medicus Shares Gain Limelight Following Half-year Results Update

February 13, 2025 01:56 PM AEDT| By Team Kalkine Media

Highlights,Revenue Boom:,Total revenue surged,32.15% to $100.79 million,, driven by North American performance.,Profit Growth:,Net profit soared,42.7% to a record $51.7 million,.,Dividend Increase:,Fully franked,interim dividend up 38.9% to 25 cents...

 Sigma Healthcare and Chemist Warehouse Combine to Create Market Buzz on ASX

Sigma Healthcare and Chemist Warehouse Combine to Create Market Buzz on ASX

February 13, 2025 01:55 PM AEDT| By Team Kalkine Media

Highlights,Sigma Healthcare and Chemist Warehouse complete merger.,Shares surge by 8.7% on debut after the merger.,The merger creates one of the largest share issues on the ASX.,In a major move that has captured the attention of the Australian market...

 Mayne Pharma's (ASX:MYX) Recent Surge: What’s Driving the Momentum?

Mayne Pharma's (ASX:MYX) Recent Surge: What’s Driving the Momentum?

February 13, 2025 01:51 PM AEDT| By Team Kalkine Media

Highlights,Mayne Pharma (,ASX:MYX,) shares jumped 26% in a month, but long-term performance,remains,moderate.,The company's price-to-sales (P/S) ratio is significantly lower than industry peers.,Revenue growth forecasts,indicate,a slower trajectory c...

 Pro Medicus (ASX: PME) Sees 42.7% Profit Surge, Driven by Major Contracts and Strong Market Growth

Pro Medicus (ASX: PME) Sees 42.7% Profit Surge, Driven by Major Contracts and Strong Market Growth

February 13, 2025 01:00 PM AEDT| By Team Kalkine Media

Highlights,Pro Medicus (ASX: PME) reports a 42.7% increase in net profit for the first half of FY24.,Record-breaking contract wins, including the largest deal in company history worth $330 million.,Company,remains,debt-free with solid cash reserves o...

 Pro Medicus (ASX:PME) Reports Strong HY25 Growth with 43% Profit Surge

Pro Medicus (ASX:PME) Reports Strong HY25 Growth with 43% Profit Surge

February 13, 2025 12:44 PM AEDT| By Team Kalkine Media

Highlights,Revenue jumped 31.1% to $97.2 million,Net profit after tax (NPAT) increased 42.7% to $51.7 million,New and renewed contracts worth over $500 million secured,Pro Medicus (ASX:PME), a leading healthcare technology provider, has delivered an...

 Australian Sharemarket Hits Record High; Sigma (ASX:SIG) Climbs 5% Following Chemist Warehouse Debut

Australian Sharemarket Hits Record High; Sigma (ASX:SIG) Climbs 5% Following Chemist Warehouse Debut

February 13, 2025 12:37 PM AEDT| By Team Kalkine Media

Highlights:,Australian market hits a new record, boosted by positive earnings results.,Sigma (SIG) shares,rise,5% following Chemist Warehouse's public debut.,Materials stocks lead the charge in driving the market's upward movement.,The Australian sto...

 Sigma Healthcare Surges as Chemist Warehouse Debuts on ASX After Major Merger

Sigma Healthcare Surges as Chemist Warehouse Debuts on ASX After Major Merger

February 13, 2025 11:31 AM AEDT| By Team Kalkine Media

Highlights:,Sigma Healthcare's shares rose by 1.8% to $2.81 following the Chemist Warehouse debut on the ASX.,The merger creates one of the largest entities on the Australian bourse, entering the S&P/ASX 100 with a $32 billion market cap.,Chemist War...

 ASX Sees Modest Gains Amid Chemist Warehouse Debut and Sigma’s Strong Performance

ASX Sees Modest Gains Amid Chemist Warehouse Debut and Sigma’s Strong Performance

February 13, 2025 11:28 AM AEDT| By Team Kalkine Media

Highlights,Chemist Warehouse Makes a Strong ASX Debut,: Chemist Warehouse merged with Sigma Healthcare and debuted with a market capitalisation of $31.8 billion, rising 1.8% during its first trading day.,Earnings Drive Market Movement,: Origin Energy...

 Is Wellnex Life Ready for Global Expansion with a Dual Listing?

Is Wellnex Life Ready for Global Expansion with a Dual Listing?

February 13, 2025 11:00 AM AEDT| By Team Kalkine Media

Highlights,Secured commitments amounting to nine million dollars for the AIM dual listing.,Eliminating convertible notes and settling deferred costs from Pain Away results in annual savings exceeding one million dollars.,A non-renounceable entitlemen...

 Guess how much $5,000 invested in Sigma shares in December 2023 is worth now!

Guess how much $5,000 invested in Sigma shares in December 2023 is worth now!

February 12, 2025 05:22 PM AEDT| By Team Kalkine Media

Guess how much $5,000 invested in Sigma shares in December 2023 is worth now!

 CSL (ASX:CSL) Faces Mixed Reactions Following First-Half Report and Analyst Adjustments

CSL (ASX:CSL) Faces Mixed Reactions Following First-Half Report and Analyst Adjustments

February 12, 2025 02:11 PM AEDT| By Team Kalkine Media

Highlights,CSL (CSL) shares continue to drop after a 5% loss on Tuesday.,Morningstar raised CSL's fair value estimate by 5%, while adjusting future earnings projections.,Analysts,remain,cautious on CSL’s flu vaccine business but optimistic about its...

 Percheron Therapeutics (ASX:PER) Advances Partnership Talks Amid Strategic Growth Plans

Percheron Therapeutics (ASX:PER) Advances Partnership Talks Amid Strategic Growth Plans

February 12, 2025 12:46 PM AEDT| By Team Kalkine Media

Highlights,Percheron Therapeutics (,ASX:PER,) expects partnership proposals for its phase IIb trial by the end of February.,The company explores new clinical candidates after the ATL1102 study outcome.,Broader strategic partnerships are being conside...

 Healthcare leaders in the ASX sector juggle multiple roles within this interconnected industry.

Healthcare leaders in the ASX sector juggle multiple roles within this interconnected industry.

February 12, 2025 11:00 AM AEDT| By Team Kalkine Media

Highlights,ASX healthcare sector leaders frequently engage with multiple companies, providing strategic insight and fostering growth.,Executives like Syntara's Gary Phillips and Dimerix's Dr Nina Webster play pivotal roles in advancing early-stage dr...

 Vitura Health Acquires Telehealth Platform for Medical Cannabis

Vitura Health Acquires Telehealth Platform for Medical Cannabis

February 12, 2025 11:00 AM AEDT| By Team Kalkine Media

Highlights,Vitura Health (ASX:VIT) expands its telehealth portfolio by acquiring Candor Medical for $5.9 million.,CSL (ASX:CSL) experiences mixed reactions to its recent financial results, with varying expert opinions.,Percheron Therapeutics (ASX:PER...

 Dr. Boreham’s Crucible: Why is Biotech Giant CSL Creating Such a Stir?

Dr. Boreham’s Crucible: Why is Biotech Giant CSL Creating Such a Stir?

February 12, 2025 11:00 AM AEDT| By Team Kalkine Media

CSL Faces Challenges and Opportunities in Flu Vaccine Market Amidst Diverging Divisional Performance

 Island finishes dosing in the Phase 2b segment of its dengue trial, spread by mosquitoes.

Island finishes dosing in the Phase 2b segment of its dengue trial, spread by mosquitoes.

February 12, 2025 11:00 AM AEDT| By Team Kalkine Media

Highlights:,Island Pharmaceuticals (ILA) successfully completes Phase 2b trial dosing for ISLA-101, focused on dengue fever treatment.,Results anticipated in the coming weeks, evaluating the drug’s effectiveness in reducing viral levels and symptoms....

 Ansell Limited Mastering Debt Management and Financial Resilience in the Medical Equipment Sector

Ansell Limited Mastering Debt Management and Financial Resilience in the Medical Equipment Sector

February 11, 2025 07:31 PM AEDT| By Team Kalkine Media

Ansell Limited Mastering Debt Management and Financial Resilience in the Medical Equipment Sector

 CSL (ASX:CSL) Shares Fall After Underperforming First-Half Results Amid Vaccine Business Struggles

CSL (ASX:CSL) Shares Fall After Underperforming First-Half Results Amid Vaccine Business Struggles

February 11, 2025 03:41 PM AEDT| By Team Kalkine Media

Highlights,CSL (CSL) misses first-half estimates.,Seqirus vaccine division,impacted,by low influenza,immunisation,rates.,Full-year revenue and NPATA guidance remain unchanged despite,results,.,Shares of CSL (ASX:CSL) experienced a dramatic reversal i...

AU_advertise

Advertise your brand on Kalkine Media

Recent Articles






Investing Tips

Previous Next
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.